Using REMS ultrasound to check bone density in children and teens with conditions that lower bone strength
Official title: Observational Study for the Assessment of Bone Mineral Density (BMD) Using REMS Technology
Run by Meyer Children's Hospital IRCCS · NCT07412782 · Data updated 2026-11-12
This project will test whether REMS, a radiation-free ultrasound method, can measure bone mineral density in children and adolescents aged 5–18 who have conditions that weaken their bones.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 18 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Meyer Children's Hospital IRCCS Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Florence, Tuscany) |
| Status | Recruiting |
| Started | December 4, 2025 |
| Main results expected | June 15, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT07412782 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 5–18 with a documented condition that negatively affects bone health who can provide consent/assent with parental permission are ideal candidates.
✕Probably not a fit
Children under 5 or over 18, those without bone-impacting conditions, or patients who require DXA-based results for immediate clinical decisions may not receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers at Meyer Children's Hospital will enroll children and adolescents aged 5–18 with conditions known to impair bone health and perform REMS (Radiofrequency Echographic Multi Spectrometry) scans to obtain bone mineral density measurements. Participants will have clinical history recorded and undergo anthropometric and pubertal assessments, with prior DXA results collected when available. The single-center, non-profit interventional protocol will run about 12 months and uses a non-invasive, radiation-free ultrasound approach. The primary aim is to describe REMS-derived BMD values in pediatric patients with osteoporosis-related conditions and generate preliminary pediatric data.
Why it matters
Potential benefit: If successful, REMS could provide a safe, radiation-free way to monitor bone density in children and reduce dependence on DXA.
How similar studies have gone: REMS has been validated for bone density measurement in adults and early pediatric reports are promising, but standardized pediatric reference values are not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent from adult patients or parents/legal guardians * Age between 5 and 18 years * Both sexes and all ethnicities * Known condition negatively affecting bone health Exclusion Criteria: \- Age below 5 years or over 18 years
Where it's running
-
AOU IRCCS Meyer
Florence, Tuscany, Italy Recruiting
Study contacts
- Study coordinator: Stefano Stagi, Professor
- Email: stefano.stagi@unifi.it
- Phone: 0039 0555662305
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Vitamin K2 supplementation for patients with low bone density and a specific gene variant
This study is testing if taking vitamin K2 can help improve bone density in adults aged 40-75 with low bone density who have a specific gene variant.
-
Using blood cells to improve osteoporosis diagnosis and monitoring
This study is testing if checking the health of certain blood cells can help doctors better diagnose and monitor osteoporosis in both men and women.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.